Suppr超能文献

表皮生长因子受体变体III(EGFRvIII)利用内在和外在机制来降低胶质瘤的黏附性并增加其迁移能力。

EGFRvIII uses intrinsic and extrinsic mechanisms to reduce glioma adhesion and increase migration.

作者信息

Banisadr Afsheen, Eick Mariam, Beri Pranjali, Parisian Alison D, Yeoman Benjamin, Placone Jesse K, Engler Adam J, Furnari Frank

机构信息

Biomedical Sciences Program, UC San Diego, La Jolla, CA 92093, USA.

Department of Bioengineering, UC San Diego, La Jolla, CA 92093, USA.

出版信息

J Cell Sci. 2020 Dec 24;133(24):jcs247189. doi: 10.1242/jcs.247189.

Abstract

A lack of biological markers has limited our ability to identify the invasive cells responsible for glioblastoma multiforme (GBM). To become migratory and invasive, cells must downregulate matrix adhesions, which could be a physical marker of invasive potential. We engineered murine astrocytes with common GBM mutations, e.g. () or deletion and expressing a constitutively active EGF receptor truncation (EGFRvIII), to elucidate their effect on adhesion. While loss of or did not affect adhesion, counterparts expressing EGFRvIII were significantly less adhesive. EGFRvIII reduced focal adhesion size and number, and these cells - with more labile adhesions - displayed enhanced migration. Regulation appears to depend not on physical receptor association to integrins but, rather, on the activity of the receptor kinase, resulting in transcriptional integrin repression. Interestingly, EGFRvIII intrinsic signals can be propagated by cytokine crosstalk to cells expressing wild-type EGFR, resulting in reduced adhesion and enhanced migration. These data identify potential intrinsic and extrinsic mechanisms that gliomas use to invade surrounding parenchyma.

摘要

缺乏生物标志物限制了我们识别多形性胶质母细胞瘤(GBM)侵袭性细胞的能力。细胞要实现迁移和侵袭,必须下调基质黏附,而这可能是侵袭潜能的一个物理标志物。我们构建了带有常见GBM突变(如()或缺失)并表达组成型活性表皮生长因子受体截短体(EGFRvIII)的小鼠星形胶质细胞,以阐明其对黏附的影响。虽然缺失或不影响黏附,但表达EGFRvIII的细胞黏附性显著降低。EGFRvIII减小了黏着斑的大小和数量,这些具有更不稳定黏附的细胞表现出增强的迁移能力。调控似乎不依赖于物理受体与整合素的结合,而是取决于受体激酶的活性,导致整合素转录抑制。有趣的是,EGFRvIII的内在信号可通过细胞因子串扰传递给表达野生型EGFR的细胞,导致黏附减少和迁移增强。这些数据确定了胶质瘤用于侵袭周围实质的潜在内在和外在机制。

相似文献

1
EGFRvIII uses intrinsic and extrinsic mechanisms to reduce glioma adhesion and increase migration.
J Cell Sci. 2020 Dec 24;133(24):jcs247189. doi: 10.1242/jcs.247189.
3
Crosstalk between the urokinase-type plasminogen activator receptor and EGF receptor variant III supports survival and growth of glioblastoma cells.
Proc Natl Acad Sci U S A. 2011 Sep 20;108(38):15984-9. doi: 10.1073/pnas.1113416108. Epub 2011 Sep 6.
4
The Impact of Oncogenic EGFRvIII on the Proteome of Extracellular Vesicles Released from Glioblastoma Cells.
Mol Cell Proteomics. 2018 Oct;17(10):1948-1964. doi: 10.1074/mcp.RA118.000644. Epub 2018 Jul 13.
7
EGFRvIII and DNA double-strand break repair: a molecular mechanism for radioresistance in glioblastoma.
Cancer Res. 2009 May 15;69(10):4252-9. doi: 10.1158/0008-5472.CAN-08-4853. Epub 2009 May 12.
8
Neutralizing the EGF receptor in glioblastoma cells stimulates cell migration by activating uPAR-initiated cell signaling.
Oncogene. 2015 Jul 30;34(31):4078-88. doi: 10.1038/onc.2014.336. Epub 2014 Oct 27.
9
EGFRvIII-Stat5 Signaling Enhances Glioblastoma Cell Migration and Survival.
Mol Cancer Res. 2018 Jul;16(7):1185-1195. doi: 10.1158/1541-7786.MCR-18-0125. Epub 2018 May 3.
10
Nimotuzumab enhances temozolomide-induced growth suppression of glioma cells expressing mutant EGFR in vivo.
Cancer Med. 2016 Mar;5(3):486-99. doi: 10.1002/cam4.614. Epub 2016 Jan 18.

引用本文的文献

2
Understanding Glioblastoma Signaling, Heterogeneity, Invasiveness, and Drug Delivery Barriers.
Int J Mol Sci. 2023 Sep 19;24(18):14256. doi: 10.3390/ijms241814256.
3
Heterogeneous expression of alternatively spliced lncRNA mediates vascular smooth cell plasticity.
Proc Natl Acad Sci U S A. 2023 Jun 13;120(24):e2217122120. doi: 10.1073/pnas.2217122120. Epub 2023 Jun 5.
5
EGFR, the Lazarus target for precision oncology in glioblastoma.
Neuro Oncol. 2022 Dec 1;24(12):2035-2062. doi: 10.1093/neuonc/noac204.
6
Anti-Survival Effect of SI306 and Its Derivatives on Human Glioblastoma Cells.
Pharmaceutics. 2022 Jul 1;14(7):1399. doi: 10.3390/pharmaceutics14071399.
7
EGFR in Cancer: Signaling Mechanisms, Drugs, and Acquired Resistance.
Cancers (Basel). 2021 Jun 1;13(11):2748. doi: 10.3390/cancers13112748.

本文引用的文献

1
The invasive proteome of glioblastoma revealed by laser-capture microdissection.
Neurooncol Adv. 2019 Sep 28;1(1):vdz029. doi: 10.1093/noajnl/vdz029. eCollection 2019 May-Dec.
2
Cell Adhesiveness Serves as a Biophysical Marker for Metastatic Potential.
Cancer Res. 2020 Feb 15;80(4):901-911. doi: 10.1158/0008-5472.CAN-19-1794. Epub 2019 Dec 19.
6
Glioblastoma cellular cross-talk converges on NF-κB to attenuate EGFR inhibitor sensitivity.
Genes Dev. 2017 Jun 15;31(12):1212-1227. doi: 10.1101/gad.300079.117. Epub 2017 Jul 19.
7
Metastatic State of Cancer Cells May Be Indicated by Adhesion Strength.
Biophys J. 2017 Feb 28;112(4):736-745. doi: 10.1016/j.bpj.2016.12.038.
9
Cancer Statistics, 2017.
CA Cancer J Clin. 2017 Jan;67(1):7-30. doi: 10.3322/caac.21387. Epub 2017 Jan 5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验